NVOS logo

Novo Integrated Sciences (NVOS) Company Overview

Profile

Full Name:

Novo Integrated Sciences, Inc.

Sector:

Healthcare

Industry:

Medical Care Facilities

Country:

United States

IPO:

February 23, 2021

Indexes:

Not included

Website:

http://www.novointegrated.com

Description:

Novo Integrated Sciences (NVOS) focuses on providing innovative solutions in healthcare and technology. The company develops products and services that improve health outcomes and enhance patient care, aiming to integrate advanced science with practical applications for better living and well-being.

Key Details

Price

$0.06

Market Cap

$1.09 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$12.57 M(+7.11% YoY)

Annual EPS

-$1.30(+88.48% YoY)

PE Ratio

-

Annual ROE

-56.78%

Annual Debt To Equity

0.09

Beta

0.26

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 7, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NVOS included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Healthcare sector
All stocks
Best performing stocks last 3 months
Small cap stocks
Stocks with low beta
Medical Care Facilities industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.06
NVOS price is $0.06

Price All-time High

$63.70
NVOS price is currently -99.91% below its historical high of $63.70

Price Analysts Target

-
NVOS price consensus analysts' forecast is unknown

Price Most Recent Change

-8.33%
NVOS price was down -8.33% on Feb 25, 2025

Price YTD Change

+5.77%
NVOS price is up +5.77% since January 1st

Price 3-Year Change

-99.6%
NVOS price is down -99.6% over the past 3 years

Market cap

Market Cap

$1.09 M
NVOS market capitalization is $1.09 million

Market Cap 3-Year Change

-97.22%
NVOS market capitalization is down -97.22% over the past 3 years

Market Cap All-time High

$152.20 M
NVOS market capitalization is currently -99.29% below its historical high of $152.20 million

Market Cap Sector Rank

3.25%
NVOS market capitalization is higher than 3.25% of companies in Healthcare sector

Technical

Beta

0.26
NVOS beta is 0.26

200-day SMA

$0.33
NVOS price is currently -83.39% below its 200-day simple moving average

14-day RSI

42.86
NVOS 14-day relative strength index is 42.86

30-day Relative Volume

0.44
NVOS 30-day relative volume is 0.44

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$12.57 M
NVOS annual revenue is $12.57 million

Annual Revenue Analysts Estimate

-
NVOS annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

+7.11%
NVOS annual revenue is up +7.11% year-on-year

Annual Revenue Sector Rank

31.77%
NVOS annual revenue is higher than 31.77% of companies in Healthcare sector

Profit

Annual Gross Profit

$4.95 M
NVOS annual gross profit is $4.95 million

Annual Gross Margin

39.39%
NVOS annual gross profit margin is 39.39%

Annual Operating Profit

-$8.55 M
NVOS annual operating income is -$8.55 million

Annual Operating Margin

-68.03%
NVOS annual operating profit margin is -68.03%

Annual Net Income

-$13.21 M
NVOS annual net profit is -$13.21 million

Annual Net Margin

-105.11%
NVOS annual net profit margin is -105.11%

EPS

Annual EPS

-$1.30
NVOS annual earnings per share is -$1.30

Annual EPS Analysts Estimate

-
NVOS annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+88.48%
NVOS annual earnings per share is up +88.48% year-on-year

Annual EPS Sector Rank

54.43%
NVOS annual earnings per share is higher than 54.43% of companies in Healthcare sector

ROA & ROE

Annual ROA

-34.58%
NVOS annual return on assets is -34.58%

Annual ROE

-56.78%
NVOS annual return on equity is -56.78%

EBIT & EBITDA

Annual EBIT

-$8.15 M
NVOS annual earnings before interest & taxes is -$8.15 million

Annual EBITDA

-$5.85 M
NVOS annual EBITDA is -$5.85 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NVOS price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NVOS price to earnings ratio is unknown

PB Ratio

PB Ratio

0.11
NVOS price to book ratio is 0.11

PB Ratio Sector Rank

18.44%
NVOS price to book ratio is higher than 18.44% of companies in Healthcare sector

PS Ratio

PS Ratio

0.08
NVOS price to sales ratio is 0.08

PS Ratio Sector Rank

4.38%
NVOS price to sales ratio is higher than 4.38% of companies in Healthcare sector

Enterprise value

Enterprise Value

$4.05 M
NVOS enterprise value is $4.05 million

Enterprise Value Sector Rank

17.43%
NVOS enterprise value is higher than 17.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.25
NVOS EV/EBITDA is -0.25

EV/EBITDA Sector Rank

61.46%
NVOS EV/EBITDA is higher than 61.46% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.56
NVOS annual current ratio is 0.56

Annual Quick Ratio

0.42
NVOS annual quick ratio is 0.42

Leverage

Annual Debt To Equity

0.09
NVOS annual debt to equity ratio is 0.09

Annual Interest Coverage Ratio

-1.59
NVOS annual interest coverage ratio is -1.59

Risk & Stability

Piotroski F-Score

3
NVOS piotroski f-score is 3

Altman Z-Score

-3.10
NVOS altman z-score is -3.10

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$35.56 M
NVOS annual total assets is $35.56 million

Annual Non Current Assets

$31.18 M
NVOS annual long term assets is $31.18 million

Annual Current Assets

$4.39 M
NVOS annual total current assets is $4.39 million

Annual Cash & Cash Equivalents

$416.30 K
NVOS annual cash & cash equivalents is $416.30 thousand

Equity

Annual Book Value

$24.82 M
NVOS annual book value is $24.82 million

Annual Working Capital

-$3.52 M
NVOS annual working capital is -$3.52 million

Liabilities

Annual Total Liabilities

$11.06 M
NVOS annual total liabilities is $11.06 million

Annual Total Long Term Liabilities

$3.16 M
NVOS annual total long term liabilities is $3.16 million

Annual Current Liabilities

$7.90 M
NVOS annual total current liabilities is $7.90 million

Annual Accounts Payable

$3.51 M
NVOS annual accounts payable is $3.51 million

Debt

Annual Total Debt

$4.47 M
NVOS annual total debt is $4.47 million

Annual Total Debt 1-Year Change

-65.59%
NVOS annual total debt is down -65.59% year-on-year

Annual Long Term Debt

$1.76 M
NVOS annual long term debt is $1.76 million

Annual Short Term Debt

$2.71 M
NVOS annual short term debt is $2.71 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$21.13 M
NVOS annual total expenses is $21.13 million

Annual Operating Expenses

$13.51 M
NVOS annual total operating expenses is $13.51 million

Annual Cost Of Goods Sold

$7.62 M
NVOS annual cost of goods sold is $7.62 million

Annual SGA

$13.51 M
NVOS annual SGA is $13.51 million

Annual D&A

$2.30 M
NVOS annual depreciation & amortization is $2.30 million

Annual Interest Expense

$5.12 M
NVOS annual interest expense is $5.12 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$2.24 M
NVOS annual cash flow from operations is -$2.24 million

Annual CFO 1-Year Change

+61.88%
NVOS annual cash flow from operations is up +61.88% year-on-year

Annual CFI

-$49.20 K
NVOS annual cash flow from investing activities is -$49.20 thousand

Annual CFI 1-Year Change

-130.09%
NVOS annual cash flow from investing activities is down -130.09% year-on-year

Annual CFF

$763.90 K
NVOS annual cash flow from financing activities is $763.90 thousand

Annual CFF 1-Year Change

+278.86%
NVOS annual cash flow from financing activities is up +278.86% year-on-year

Free CashFlow

Annual FCF

-$2.29 M
NVOS annual free cash flow is -$2.29 million

Annual FCF 1-Year Change

+62.26%
NVOS annual free cash flow is up +62.26% year-on-year

CAPEX

Annual CAPEX

$49.20 K
NVOS annual capital expenditures is $49.20 thousand

Annual CAPEX 1-Year Change

-74.13%
NVOS annual capital expenditures is down -74.13% year-on-year

Institutional Ownership

Similar stocks

PTPI logo
Petros Pharmaceuticals (PTPI)
TCBP logo
TC Biopharm (Holdings) (TCBP)
ADTX logo
Aditxt (ADTX)
BIOC logo
Biocept (BIOC)
BIOR logo
Biora Therapeutics (BIOR)
CWBR logo
CohBar (CWBR)
VIRX logo
Viracta Therapeutics (VIRX)
DYNT logo
Dynatronics (DYNT)
NAOV logo
NanoVibronix (NAOV)

FAQ

  • What is the ticker symbol for Novo Integrated Sciences?
  • Does Novo Integrated Sciences pay dividends?
  • What sector is Novo Integrated Sciences in?
  • What industry is Novo Integrated Sciences in?
  • What country is Novo Integrated Sciences based in?
  • When did Novo Integrated Sciences go public?
  • Is Novo Integrated Sciences in the S&P 500?
  • Is Novo Integrated Sciences in the NASDAQ 100?
  • Is Novo Integrated Sciences in the Dow Jones?
  • When was Novo Integrated Sciences's last earnings report?
  • When does Novo Integrated Sciences report earnings?

What is the ticker symbol for Novo Integrated Sciences?

The ticker symbol for Novo Integrated Sciences is NASDAQ:NVOS

Does Novo Integrated Sciences pay dividends?

No, Novo Integrated Sciences does not pay dividends

What sector is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Healthcare sector

What industry is Novo Integrated Sciences in?

Novo Integrated Sciences is in the Medical Care Facilities industry

What country is Novo Integrated Sciences based in?

Novo Integrated Sciences is headquartered in United States

When did Novo Integrated Sciences go public?

Novo Integrated Sciences's initial public offering (IPO) was on February 23, 2021

Is Novo Integrated Sciences in the S&P 500?

No, Novo Integrated Sciences is not included in the S&P 500 index

Is Novo Integrated Sciences in the NASDAQ 100?

No, Novo Integrated Sciences is not included in the NASDAQ 100 index

Is Novo Integrated Sciences in the Dow Jones?

No, Novo Integrated Sciences is not included in the Dow Jones index

When was Novo Integrated Sciences's last earnings report?

Novo Integrated Sciences's most recent earnings report was on Feb 19, 2025

When does Novo Integrated Sciences report earnings?

The date for Novo Integrated Sciences's next earnings report has not been announced yet